Fum, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce positive data from its pharmacokinetic pk study fm58 of med2002, the companys topical gel for erectile dysfunction ed. Gel that works on erectile dysfunction in just five. Fum complete futura medical plc stock news by marketwatch. User friendly, easy to use, and affordable medical practice management system for physicians and medical professionals. Futura medical plcs phase 3 data for med2005 could drive. Brought to us by futura medical the med2002 or also known under its brand name eroxon, this is a new and improved topical treatment for erectile dysfunction that can help men all over the world. Med2005 or med2002 are the codename s used by futura for all proprietary formulations of gtn. Guildfordbased futura medicals med2002, branded as eroxon, could be set to overtake viagra as the goto erectile dysfunction treatment.
The following slide deck was published by futura medical plc in conjunction with this event. This product uses the med2002 topical gel formulation and incorporates dermasys futura medical plc. Med2002 is male enhancement gel that has been designed to be applied topically on the male organ to help treat erectile dysfunction. The futura medical med2002 solution provides an effective alternative to dangerous surgical operations or oral medication. Get a free 7 day trial of medical billing software. New clinical data provide additional validation for the safety and. Futura medical shifts focus to med2002 treatment as. Headline results from the trial of med2005 are due before the end of 2019, while futura is also confident of hearing back from uk regulators. Med3000 is now the codename for a formulation of dermasys developed specifically for the treatment of ed. Futura medical begins recruitment for med2002 safety trial. Consisting of a topical lotion that is applied to the glans of the penis, med2002 is non irritant, non invasive, discreet, and easy to apply. Founded in a basement in 1979, epic develops software to help people get well, help people stay well, and help future generations be healthier.
Med2002 is the codename used by futura for all proprietary formulations of gtn. Fum james barder tells proactive the company has seen a very good year of progress with its med2002 erectile dysfunction gel as. Futura medical plc positive data from med2002 pk study. Futura medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal dermasys technology. Futura medical plc shifts focus to med2002 treatment as. Fum, tells proactive theyve begun recruitment for a pharmacokinetic study of their lead product, med2002. Eroxon is the registered and suggested brand name for futura s topical gel for ed, though potential distributors may choose to use other brand names. Fum, tells proactive theyve begun recruitment for a pharmacokinetic study of their. The first european phase 3 study for med2002, referred to as fm57, is a 1,000 patient. Futura medical plc looking ahead to completion of key phase iii ed.
The directors plan to take med2002 through phase 3 development and then. Kincora copper begins drilling program at trundle project in new south wales. Efficacy and safety of med2005, a topical glyceryl trinitrate. What is eroxon or med2002 eroxon is a topical gel for erectile dysfunction developed by futura medical. Fum james barder tells proactive the company has seen a very good year of progress with its med2002 erectile dysfunction gel as the company reports its half year. Futura medical presents data on med2005 for the treatment of. Software firm sopheon suffered a shock, tumbling 19 per cent to. Futura medical is the pharmaceutical company that is behind this male sexual enhancement gel. Futura medical plc says it may have found simpler route to. Futura medical endured a bittersweet week following a surprising result. Futura medical plc raises funds to finance its erectile dysfunction.
Level the playing field with access to the latest investment research. Futura medical begins recruitment for med2002 safety trial youtube. Futura medical is developing a portfolio of innovative products for two large markets, sexual health and pain. Equity research, broker reports, and media content available to private and noninstitutional investors. Fum james barder tells proactive the company has seen a very good year of progress with its med2002 erectile dysfunction gel as the company reports its half year results. Its main ingredient is glyceryl trinitrate, which is known to be a powerful vasodilator. Futura has a proven track record in delivery and completion of. It lays primary focus exclusively on topically applied pharmaceutical drugs and. Topical alprostadil cream for the treatment of erectile dysfunction. Futura medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal dermasys drug delivery technology. Fum, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the outcome of the detailed analysis of the results of the recent. Futura medical famdf med2002 treatment for erectile. James barder, chief executive of futura medical plc lon. Futura medical med2002 a new gel treatment for erectile.
1481 1452 421 1328 1430 875 21 902 1479 10 645 34 570 1493 621 258 443 807 72 557 6 489 602 1011 651 302 828 756 1040 853 493 307 615 1163 807 1014 39 1084 383 247 432 17 581 1376